1 citations
,
September 2023 in “Journal of the American Academy of Dermatology” This study focused on baricitinib's effect on patients with severe alopecia areata, highlighting its efficacy for hair regrowth and its potential to improve health-related quality of life and psychological symptoms, as seen in two phase 3 trials.
4 citations
,
March 2023 in “SKIN The Journal of Cutaneous Medicine” This abstract does not provide specific results or a conclusion; additional context is needed to interpret the data.
3 citations
,
June 2023 in “Journal of dermatological treatment” This study found that patients with severe alopecia areata who experienced meaningful scalp hair regrowth showed greater improvements in health-related quality of life and reduced anxiety and depression compared to those with no or minimal regrowth.
June 2026 in “Drugs & Therapy Perspectives” This study reports that patients with severe alopecia areata who experienced sustained scalp regrowth while receiving continuous baricitinib treatment showed improvements in health-related quality of life and reductions in anxiety and depression symptoms.
June 2024 in “Research Square (Research Square)” This study observed that combining botulinum toxin type A with Minoxidil significantly promoted hair growth, improved quality of life, and enhanced patient satisfaction in male androgenetic alopecia patients at 4 and 6 months, with no adverse effects compared to using Minoxidil alone.
